NCT00993616 2019-07-23Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or CisplatinNational Cancer Institute (NCI)Phase 2 Completed29 enrolled 9 charts